- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,521GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,521GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,521GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,521GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,521GBP
- Report
- June 2026
- 483 Pages
Global
From €5325EUR$5,850USD£4,588GBP
- Report
- June 2026
- 470 Pages
Global
From €5325EUR$5,850USD£4,588GBP
- Report
- June 2026
- 384 Pages
Global
From €5325EUR$5,850USD£4,588GBP
- Report
- June 2026
- 482 Pages
Global
From €5325EUR$5,850USD£4,588GBP
- Report
- August 2025
- 193 Pages
Global
From €3227EUR$3,545USD£2,780GBP
€3585EUR$3,939USD£3,089GBP
- Report
- July 2025
- 350 Pages
Global
From €4505EUR$4,949USD£3,881GBP
- Report
- July 2025
- 350 Pages
Global
From €4505EUR$4,949USD£3,881GBP
- Report
- June 2026
- 149 Pages
Global
From €3640EUR$3,999USD£3,136GBP
- Report
- April 2026
- 148 Pages
Global
From €3640EUR$3,999USD£3,136GBP
- Report
- January 2026
- 140 Pages
Global
From €3595EUR$3,950USD£3,098GBP
- Report
- November 2025
- 150 Pages
Global
From €4415EUR$4,850USD£3,804GBP
- Report
- September 2025
- 104 Pages
Global
From €3500EUR$4,119USD£3,121GBP
- Report
- September 2025
- 117 Pages
Global
From €3500EUR$4,119USD£3,121GBP
- Report
- November 2025
- 203 Pages
Global
From €4506EUR$4,950USD£3,882GBP
- Report
- April 2026
- 150 Pages
North America
From €3640EUR$3,999USD£3,136GBP

The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more